AntineoplasticsLack of efficacy and off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1938卷 / 1期

关键词：

D O I：

10.1007/s40278-023-30285-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：144 / 144

相关论文

共 50 条

[41] Axitinib/sunitinibLack of efficacy and off label use: case report
Reactions Weekly, 2022, 1914 (1) : 101 - 101
[42] BevacizumabLack of efficacy and off-label use: case report
Reactions Weekly, 2025, 2042 (1) : 81 - 81
[43] Multiple drugsLack of efficacy and off label use: case report
Reactions Weekly, 2021, 1885 (1) : 357 - 357
[44] AcetylcysteineLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1900 (1) : 16 - 16
[45] Immunosuppressants/molnupiravirLack of efficacy and off label use: case report
Reactions Weekly, 2023, 1943 (1) : 362 - 362
[46] Furosemide/remdesivirLack of efficacy and off label use: case report
Reactions Weekly, 2023, 1954 (1) : 219 - 219
[47] DexamethasoneLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1910 (1) : 178 - 178
[48] Multiple drugsLack of efficacy and off label use: case report
Reactions Weekly, 2024, 2036 (1) : 314 - 314
[49] Multiple drugsLack of efficacy and off label use: case report
Reactions Weekly, 2023, 1981 (1) : 270 - 270
[50] Acetylcysteine/DexamethasoneLack of efficacy and off label use: case report
Reactions Weekly, 2025, 2056 (1) : 20 - 20

← 1 2 3 4 5 →